Exam 1 Flashcards

1
Q

List the 6 community pharmacy workflow steps in the correct order

A

Prescription is received by the pharmacy
Data Entry
Pre Check
Dispensing
Final Check
Patient receives the prescription and counseling (pick up)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Written Prescription Requirements

A

Date Rx issued
Full name and title of prescriber
Physical Address of prescriber practice location (no P.O. box)
Telephone number of prescriber

Full name of patient
Address of patient

Drug name and strength
Quantity to dispense
Directions for drug use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

DEA# check formula

A

2 letters and 7 numbers (last number is a check digit)
-First letter is type of practitioner
-Second letter is first initial of prescribers last name

First step: add 1st, 3rd, and 5th numbers
Second step: add 2nd, 4th, 6th numbers and multiply by 2
Third step: add sums together and check that last digit matches check

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

A pharmacist shall not dispense a dangerous drug (CV) for the first time beyond __________ from the date a prescription was written

A

6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

A prescription for an outpatient opioid analegesic (CII-CIV) must be filled for the first time within ______ of the date the prescription was written

A

14 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

_______ refills may be writeen on a prescription for a C-II controlled substance

A

Zero

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Refills for C-III and C-IV controlled substances are valid for _____________ from the date the prescription was written

A

6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Refills for non-controlled and C-V controlled substances are valid for _________ from the date the prescription was written

A

1 year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is drug information

A

the retrieval, evaluation, and communication of medication information in order to give to patients

systematic approach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is evidence-based medicine

A

systematic approach to clinical problem-solving
uses public literature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the basic drug information skills needed by all pharmacists

A

identify info needed to solve problems
define actual drug information needed from request
define timeframe for provision of answer and adjust
obtain background needed to answer most drug info
obtain background needed to answer specific drug info
effectively use info
communicate info
monitor patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the steps of systematic approach to using and providing drug information

A

Classify the request
Obtain background information
Systematic literature search
Formulation and communication of a response
Follow-up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Definition of tertiary literature

A

Information that has been gathered and summarized by editors, authors, experts
Summarizes and interprets the original work of others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Example of tertiary literature

A

Textbooks
Reference books/databases
drug monographs
review articles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are some advantages and disadvantages of tertiary literature

A

Advantages: convenient, accessible, easy to use
Disadvantages: may not be up to date, information reflects authors interpretation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How to evaluate a tertiary resource

A

Who are the authors
year of publication
are there references
are the references used appropriately, does it have enough
how easy is it to use

17
Q

Defn of drug monograph

A

Factual document on drug product that describes the properties, claims, indications, and conditions of use of the drug and contains info to use the drug safely

18
Q

What are some parts of a drug monograph

A

Pharmacology- mechanism of action, what drug does
Pharmacokinetics-ADME
Contradictions
Warning and precautions
Indications of use (FDA approved or not)
Overdose/Tox
Blackbox warnings

19
Q

What are the 5 steps of patient care process (PPCP)

A

Collect
Assess
Plan
Implement
Follow-up

20
Q

What is the purpose of documentation for for PPCP

A

communication
contribution to patient care
ensure continuity of care
protect professional liability
reimbursement

21
Q

What is subjective data

A

descriptive in nature
obtained by listening to patient
info from responses

22
Q

CC
HPI
ROS
PMH
SH
FM

A

chief complaint
history of present illness
review of systems
past medical history
social history
family history

23
Q

What is objective data

A

Direct measurement or observation
lab tests
vital signs
calculated data

24
Q

How to calculate IBW for males and females

A

male: 50 + 2.3 (every inch over 5 feet)
female: 45.5 + 2.3 (every inch over 5 feet)

25
Q

How to calculate BMI for males and females

A

(weight in pounds * 703) / (height^2)
*always round to one decimal place

26
Q

How to calculate creatine clearance (CrCl)

A

(140-age)(IBW) / (72)(Scr)
*if female multiply by 0.85
*round to nearest whole number

27
Q

What is the exception to CrCl

A

if patient actual body weight is under IBW then use ABW

28
Q

What are drug related problems

A

Issues surrounding drug therapy
Actually (or potentially) interfere with optimal therapeutic outcomes

29
Q

What does NDC 1st number, middle #, and last # indicate

A

first: manufacturer
middle: drug/dose/dosage form
last: package size

30
Q

USAN

A

official name of drug recognized by the United States

30
Q

Proprietary name

A

brand name, trade name, product name

30
Q

Nonproprietary name

A

generic name, active ingredient, drug name

30
Q

INN

A

naming system managed by the World Health Organization

31
Q

What does the FDA consider pharmaceutical equivalents

A

some active ingredients, same dosage form, same route, same strength

32
Q

Generic Equivalence

A

no bioequivalence problems

33
Q

Therapeutic Equivalence

A

pharmaceutical equivalent and behave like each other

34
Q

If the first letter of the therapeutic equivalence ratings code begins with B

A

There is Bioequivalence problems

35
Q

If the first letter of the therapeutic equivalence ratings code begins with A

A

There is equivalence